Skip to main content

View Diary: (86 comments)

Comment Preferences

  •  Here ya go (1+ / 0-)
    Recommended by:

    In Europe, flu vaccines are usually tested on hundreds of people for several weeks or months, to ensure the immune system produces enough antibodies to fight the infection.

    But to ensure swine flu vaccine is available as soon as possible, the European Medicines Agency is allowing companies to skip testing in large numbers of people before the vaccine is approved.

    The main issue is probably that without thorough testing it's difficult to gauge the effective dosage — meaning Europeans might get too weak a vaccine. It's unlikely the vaccine would endanger anyone, but until it is used in large numbers of people, no one will know for sure.

    Perhaps you're happy that Big Pharma apparently used Europeans as guinea pigs?

Subscribe or Donate to support Daily Kos.

Click here for the mobile view of the site